Company / Free Cash Flow per Share
Neogen Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.11
FY2025
5-year range
-$0.71 / $0.58
FY2021-FY2025
Trend
+46.8%
vs FY2024
Sector context
#121 of 148
Health Care
What the data says
Neogen's free cash flow per share of $-0.11 is lower than 82% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-0.71 in FY2023 to $0.92 in FY2020.
Based on SEC 10-K filings.
-0.11 in FY2025.
Improved from $-0.71 to $-0.11 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 148This company -$0.11 Sector average $5.04
▼
-102.3% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 46.8% year-over-year.
- Ranks #121 out of 148 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2020.
- Lowest free cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.11 | +46.8% |
| FY2024 | -$0.21 | +69.7% |
| FY2023 | -$0.71 | -222.8% |
| FY2022 | $0.58 | +23.9% |
| FY2021 | $0.46 | -49.7% |
| FY2020 | $0.92 | +4.5% |
| FY2019 | $0.88 | +113.1% |
| FY2018 | $0.41 | -54.4% |
| FY2017 | $0.91 | +233.6% |
| FY2016 | $0.27 | -43.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026